ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 200 filers reported holding ARGENX SE in Q1 2022. The put-call ratio across all filers is 0.51 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $589,956 | -88.8% | 1,200 | -91.5% | 0.02% | -89.5% |
| Q1 2023 | $5,290,636 | +145.7% | 14,200 | +149.8% | 0.22% | +93.0% |
| Q4 2022 | $2,153,270 | +366.1% | 5,684 | +334.2% | 0.11% | +533.3% |
| Q3 2022 | $462,000 | -91.0% | 1,309 | -90.3% | 0.02% | -91.9% |
| Q2 2022 | $5,115,000 | +1726.8% | 13,500 | +1587.5% | 0.22% | +1127.8% |
| Q4 2021 | $280,000 | -71.2% | 800 | -78.4% | 0.02% | -90.8% |
| Q3 2020 | $971,000 | – | 3,700 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
| Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
| Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
| Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
| Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
| Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
| Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
| DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
| SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
| RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |